Rachel Dennison

Harvard University

Papers

1

Total Citations

56

H-Index

1

About

Dr. Rachel Dennison is a leading figure in translational neuroscience, whose work bridges the critical gap between acute spinal cord injury (SCI) and long-term functional recovery. Her research focuses on non-invasive therapeutic strategies, combining targeted pharmacological interventions with advanced multimodal device technologies to promote neural plasticity and regeneration. In her landmark 2021 paper, "Non-invasive approaches to functional recovery after spinal cord injury: Therapeutic targets and multimodal device interventions," which has garnered 56 citations, Dr. Dennison systematically mapped the key molecular and cellular targets for repair—such as neurotrophin signaling and glial scar modulation—while evaluating the synergistic potential of electrical stimulation, robotics, and optogenetics. This work has provided a foundational framework for developing safer, scalable rehabilitation protocols that avoid the risks of invasive surgery. Her contributions have been recognized with early-career awards from the Society for Neuroscience, and she is a sought-after speaker on integrating engineering principles into clinical neurology. For students and researchers, Dr. Dennison’s research represents a paradigm shift: moving from merely mitigating damage to actively rebuilding function through intelligent, patient-friendly technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Non-invasive approaches to functional recovery after spinal cord injury: Therapeutic targets and multimodal device interventions
56 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Harvard University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago